Pfizer shares, which had risen Tuesday morning after improved demand for the Covid vaccine, dropped 2.3% after Kennedy's ...

(Reuters) -Drugmaker Pfizer posted a better than expected fourth quarter profit on Thursday, helped by cost cuts and a ...

A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...

Amid rising concerns over an increase in sudden deaths among young people in Karnataka, Chief Minister Siddaramaiah has ...

With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, ...

The Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...

Michigan's largest health system urges patients to seek nonemergency care at sites other than its ERs amid a surge in flu, ...

The following letter from the American Health Care Association and National Center for Assisted Living was sent to the National Governors Association and state governors ...

Dr Sonali Mukherjee-Bose told a colleague there would be ‘no risk and good remuneration’ if they created the fake documents ...

(HealthDay News) — Three main themes may largely explain COVID-19 vaccine hesitancy among Black women in the United States: mistrust in health care and government, concerns over vaccine safety, and ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...